High Intensity Focused Ultrasound Market Size to Hit USD 2.7 Billion by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on High Intensity Focused Ultrasound Market

5.1. COVID-19 Landscape: High Intensity Focused Ultrasound Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global High Intensity Focused Ultrasound Market, By Application / Clinical Indication

8.1. High Intensity Focused Ultrasound Market Revenue and Volume Forecast, by Application / Clinical Indication

8.1.1. Oncology

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Gynecology

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Neurology

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Urology (Non-cancerous BPH treatment)

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Cardiology

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Aesthetics & Body Contouring

8.1.6.1. Market Revenue and Volume Forecast

Chapter 9. Global High Intensity Focused Ultrasound Market, By Technology / Modality

9.1. High Intensity Focused Ultrasound Market Revenue and Volume Forecast, by Technology / Modality

9.1.1. Thermal Ablation HIFU

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Non-thermal / Mechanical HIFU

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. MR-guided HIFU (MRgHIFU)

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Ultrasound-guided HIFU

9.1.4.1. Market Revenue and Volume Forecast

Chapter 10. Global High Intensity Focused Ultrasound Market, By End User

10.1. High Intensity Focused Ultrasound Market Revenue and Volume Forecast, by End User

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Ambulatory Surgery Centers

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Specialty Clinics (Aesthetics, Urology, Gynecology)

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Academic & Research Institutes

10.1.4.1. Market Revenue and Volume Forecast

Chapter 11. Global High Intensity Focused Ultrasound Market, By Product Type

11.1. High Intensity Focused Ultrasound Market Revenue and Volume Forecast, by Product Type

11.1.1. Therapeutic HIFU Systems

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Aesthetic HIFU Devices

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Portable / Compact HIFU Systems

11.1.3.1. Market Revenue and Volume Forecast

Chapter 12. Global High Intensity Focused Ultrasound Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.1.2. Market Revenue and Volume Forecast, by Technology / Modality

12.1.3. Market Revenue and Volume Forecast, by End User

12.1.4. Market Revenue and Volume Forecast, by Product Type

12.1.5. U.S.

12.1.5.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.1.5.2. Market Revenue and Volume Forecast, by Technology / Modality

12.1.5.3. Market Revenue and Volume Forecast, by End User

12.1.5.4. Market Revenue and Volume Forecast, by Product Type

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.1.6.2. Market Revenue and Volume Forecast, by Technology / Modality

12.1.6.3. Market Revenue and Volume Forecast, by End User

12.1.6.4. Market Revenue and Volume Forecast, by Product Type

12.2. Europe

12.2.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.2.2. Market Revenue and Volume Forecast, by Technology / Modality

12.2.3. Market Revenue and Volume Forecast, by End User

12.2.4. Market Revenue and Volume Forecast, by Product Type

12.2.5. UK

12.2.5.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.2.5.2. Market Revenue and Volume Forecast, by Technology / Modality

12.2.5.3. Market Revenue and Volume Forecast, by End User

12.2.5.4. Market Revenue and Volume Forecast, by Product Type

12.2.6. Germany

12.2.6.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.2.6.2. Market Revenue and Volume Forecast, by Technology / Modality

12.2.6.3. Market Revenue and Volume Forecast, by End User

12.2.6.4. Market Revenue and Volume Forecast, by Product Type

12.2.7. France

12.2.7.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.2.7.2. Market Revenue and Volume Forecast, by Technology / Modality

12.2.7.3. Market Revenue and Volume Forecast, by End User

12.2.7.4. Market Revenue and Volume Forecast, by Product Type

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.2.8.2. Market Revenue and Volume Forecast, by Technology / Modality

12.2.8.3. Market Revenue and Volume Forecast, by End User

12.2.8.4. Market Revenue and Volume Forecast, by Product Type

12.3. APAC

12.3.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.3.2. Market Revenue and Volume Forecast, by Technology / Modality

12.3.3. Market Revenue and Volume Forecast, by End User

12.3.4. Market Revenue and Volume Forecast, by Product Type

12.3.5. India

12.3.5.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.3.5.2. Market Revenue and Volume Forecast, by Technology / Modality

12.3.5.3. Market Revenue and Volume Forecast, by End User

12.3.5.4. Market Revenue and Volume Forecast, by Product Type

12.3.6. China

12.3.6.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.3.6.2. Market Revenue and Volume Forecast, by Technology / Modality

12.3.6.3. Market Revenue and Volume Forecast, by End User

12.3.6.4. Market Revenue and Volume Forecast, by Product Type

12.3.7. Japan

12.3.7.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.3.7.2. Market Revenue and Volume Forecast, by Technology / Modality

12.3.7.3. Market Revenue and Volume Forecast, by End User

12.3.7.4. Market Revenue and Volume Forecast, by Product Type

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.3.8.2. Market Revenue and Volume Forecast, by Technology / Modality

12.3.8.3. Market Revenue and Volume Forecast, by End User

12.3.8.4. Market Revenue and Volume Forecast, by Product Type

12.4. MEA

12.4.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.4.2. Market Revenue and Volume Forecast, by Technology / Modality

12.4.3. Market Revenue and Volume Forecast, by End User

12.4.4. Market Revenue and Volume Forecast, by Product Type

12.4.5. GCC

12.4.5.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.4.5.2. Market Revenue and Volume Forecast, by Technology / Modality

12.4.5.3. Market Revenue and Volume Forecast, by End User

12.4.5.4. Market Revenue and Volume Forecast, by Product Type

12.4.6. North Africa

12.4.6.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.4.6.2. Market Revenue and Volume Forecast, by Technology / Modality

12.4.6.3. Market Revenue and Volume Forecast, by End User

12.4.6.4. Market Revenue and Volume Forecast, by Product Type

12.4.7. South Africa

12.4.7.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.4.7.2. Market Revenue and Volume Forecast, by Technology / Modality

12.4.7.3. Market Revenue and Volume Forecast, by End User

12.4.7.4. Market Revenue and Volume Forecast, by Product Type

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.4.8.2. Market Revenue and Volume Forecast, by Technology / Modality

12.4.8.3. Market Revenue and Volume Forecast, by End User

12.4.8.4. Market Revenue and Volume Forecast, by Product Type

12.5. Latin America

12.5.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.5.2. Market Revenue and Volume Forecast, by Technology / Modality

12.5.3. Market Revenue and Volume Forecast, by End User

12.5.4. Market Revenue and Volume Forecast, by Product Type

12.5.5. Brazil

12.5.5.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.5.5.2. Market Revenue and Volume Forecast, by Technology / Modality

12.5.5.3. Market Revenue and Volume Forecast, by End User

12.5.5.4. Market Revenue and Volume Forecast, by Product Type

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Volume Forecast, by Application / Clinical Indication

12.5.6.2. Market Revenue and Volume Forecast, by Technology / Modality

12.5.6.3. Market Revenue and Volume Forecast, by End User

12.5.6.4. Market Revenue and Volume Forecast, by Product Type

Chapter 13. Company Profiles

13.1. Insightec Ltd. (MR-guided HIFU, neurology)

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Philips Healthcare (MRgFUS collaboration)

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Ulthera (Merz Aesthetics – Ultherapy facial tightening)

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Bionics Co., Ltd. (Asian HIFU device manufacturer)

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Image Guided Therapy (IGT)

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Medsonic Ltd. (ultrasound-guided devices)

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. WONTECH Co., Ltd. (aesthetic HIFU systems)

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. ENDYMED Medical Ltd. (RF + ultrasound hybrids)

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Shandong Huamei Technology (China – aesthetic HIFU systems)

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. EDAP TMS (urology, oncology)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The high intensity focused ultrasound market size is expected to increase from USD 1.34 billion in 2024 to USD 2.7 billion by 2034.

The high intensity focused ultrasound market is expected to grow at a compound annual growth rate (CAGR) of around 7.26% from 2025 to 2034.

The major players in the high intensity focused ultrasound market include Insightec Ltd., EDAP TMS, Chongqing Haifu Medical Technology, Philips Healthcare, SonaCare Medical, Profound Medical, Alpinion Medical Systems, Theraclion, Classys Inc, Ulthera (Merz Aesthetics, Hironic Co., Ltd., Bionics Co., Ltd., HIFU Prostate Services, Image Guided Therapy, Luminis Ltd., Medsonic Ltd., WONTECH Co., Ltd., ENDYMED Medical Ltd, Shenzhen Wikkon, and Shandong Huamei Technology

The driving factors of the high intensity focused ultrasound market are the rising demand for non-invasive therapeutic and aesthetic procedures, technological advancements, and increasing prevalence of chronic conditions like cancer.

North America region will lead the global high intensity focused ultrasound market during the forecast period 2025 to 2034.